9 METERS BIOPHARMA, INC. Annual Net Income (Loss) Attributable to Parent in USD from 2015 to 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
9 Meters Biopharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2015 to 2022.
  • 9 Meters Biopharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2023 was -$13.9M, a 22.2% decline year-over-year.
  • 9 Meters Biopharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2023 was -$46.3M, a 8.39% decline year-over-year.
  • 9 Meters Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$43.8M, a 19% decline from 2021.
  • 9 Meters Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$36.8M, a 40.2% increase from 2020.
  • 9 Meters Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$61.5M, a 127% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$43.8M -$6.99M -19% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-28
2021 -$36.8M +$24.7M +40.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-28
2020 -$61.5M -$34.4M -127% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-23
2019 -$27M -$2.89M -11.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-22
2018 -$24.2M -$12.6M -108% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-20
2017 -$11.6M -$5.39M -86.8% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 -$6.21M +$2.53M +28.9% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-14
2015 -$8.74M Jan 1, 2015 Dec 31, 2015 10-K 2017-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.